Skip to main content

Table 1 Characteristics of patients taking antithrombotic agents who underwent endoscopic mucosal resection of colorectal polyps with injection of epinephrine–saline (Group A) or hypertonic saline (Group B)

From: Colorectal endoscopic mucosal resection with submucosal injection of epinephrine versus hypertonic saline in patients taking antithrombotic agents: propensity-score-matching analysis

 Group AGroup BP value
Number of patients (n)102102 
 Age (years)73.7 ± 8.773.7 ± 8.30.97
 Sex, males84 (82.4%)84 (82.4%)1.00
 Alcohol drinking39 (39.8%)37 (37.7%)0.88
 Smoking36 (36.7%)33 (33.7%)0.77
 BMI (kg/m2)23.5 ± 3.923.2 ± 3.60.57
 History of colonoscopy91 (89.2%)91 (89.2%)1.00
 Using laxatives22 (21.6%)17 (16.8%)0.48
Comorbidity
 Cardiovascular diseases32 (31.3%)27 (26.5%)0.54
 Cerebrovascular diseases22 (21.6%)27 (26.5%)0.42
 Chronic kidney diseases11 (10.8%)10 (9.8%)1.00
 Chronic liver damage4 (3.9%)2 (2.0%)0.68
 Diabetes mellitus31 (30.4%)35 (34.3%)0.65
 Hypertension79 (77.5%)84 (82.3%)0.49
 Malignant diseases26 (25.5%)23 (22.6%)0.74
 Charlson comorbidity score2.2 ± 1.32.2 ± 1.41.00
Operators of procedure
 Trainees72 (70.6%)50 (49.0%)0.003
 Specialists30 (29.4%)52 (51.0%) 
  1. Results are presented as mean ± SD or number of patients